Vistagen Therapeutics (VTGN) EPS (Basic) Growth (1y) (2013 - 2026)
Vistagen Therapeutics (VTGN) EPS (Basic) Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | -16.29% |
| 10 | Vistagen Therapeutics | 10.41 Mn | 10.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00% |
| Dec 31, 2025 | 2.46% |
| Sep 30, 2025 | -28.37% |
| Jun 30, 2025 | -34.80% |
| Mar 31, 2025 | 10.30% |
| Dec 31, 2024 | -112.31% |
| Sep 30, 2024 | 35.50% |
| Jun 30, 2024 | 62.52% |
| Mar 31, 2024 | 72.00% |
| Dec 31, 2023 | 84.74% |
| Sep 30, 2023 | 74.14% |
| Jun 30, 2023 | 67.42% |
| Mar 31, 2023 | 30.52% |
| Dec 31, 2022 | 11.11% |
| Sep 30, 2022 | -24.03% |
| Jun 30, 2022 | -124.25% |
| Mar 31, 2022 | 75.44% |
| Dec 31, 2021 | 23.84% |
| Sep 30, 2021 | -25.44% |
| Jun 30, 2021 | 36.73% |